Connor, Clark & Lunn Investment Management (CC&L)’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,412
Closed -$30.9K 1595
2024
Q1
$30.9K Buy
+1,412
New +$31.3K ﹤0.01% 1493

Other funds holding OPTN

Connor, Clark & Lunn Investment Management (CC&L)'s OPTN Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 1,412 shares — an estimated $30.9K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OPTN in Q1 2024 and held it in 1 quarter. The position peaked at $30.9K in Q1 2024. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,412 OptiNose shares in Q2 2024, an estimated $30.9K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OptiNose in Q1 2024 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s OptiNose position peaked at $30.9K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.